Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129486) titled 'Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins' on Aug. 12.
Study Type: Observational
Primary Sponsor: Kun-Ta Chou
Condition:
Obstructive Sleep Apnea (OSA)
Non-OSA
Intervention:
Device: CPAP
Recruitment Status: Not recruiting
Date of First Enrollment: August 2025
Target Sample Size: 120
Countries of Recruitment:
Taiwan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07129486
Published by HT Digital Content Services with permission from Health Daily Digest....